Michael Kyriakides

Directeur/Membre du Conseil chez

Purespring Therapeutics Ltd.

Consumer Services

Finance

Health Technology

Profil

Michael Kyriakides is a Board Member at Purespring Therapeutics Ltd. since 2022.
Formerly, Mr. Kyriakides was an Investment Partner at Syncona Partners LLP.
Mr. Kyriakides completed undergraduate, graduate, and doctorate degrees at Imperial College London in 2010, 2011, and 2014 respectively.

Postes actifs de Michael Kyriakides

Sociétés	Poste	Début
Purespring Therapeutics Ltd. Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases	Directeur/Membre du Conseil	01/04/2022

Tous les postes actifs de Michael Kyriakides

Anciens postes connus de Michael Kyriakides

Sociétés	Poste	Fin
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Private Equity Investor	-

Voir l'expérience en détail de Michael Kyriakides

Formation de Michael Kyriakides

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Michael Kyriakides

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	3
Imperial College London Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Finance
Purespring Therapeutics Ltd. Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases	Health Technology